Mesenchymal Stem Cell Therapies in Wound Healing

Mesenchymal stem cells (MSCs) have emerged as a cornerstone of contemporary regenerative medicine, harnessed to accelerate wound healing through multipronged mechanisms. Drawn from diverse sources such as bone marrow, adipose tissue and perinatal tissues, MSCs contribute to repair via direct differentiation into skin cell lineages and, more significantly, by orchestrating the wound microenvironment. Through paracrine signalling, MSCs secrete growth factors and cytokines that modulate inflammation, stimulate angiogenesis, promote granulation tissue formation and guide extracellular matrix remodelling. These actions culminate in faster wound closure, restoration of normal skin architecture and reduced scarring across acute and chronic wound models, including diabetic ulcers. Translation of MSC therapy has advanced with the development of bio-engineered delivery systems—such as hydrogels, scaffolds and cell sheets—to enhance cell viability, retention and functional integration at the wound site. As the field moves towards clinical adoption, standardisation of cell sourcing, dosing protocols and delivery platforms remains essential to ensure reproducible outcomes and scalable therapies for global healthcare challenges.

Research from Nature Portfolio

Recent studies have demonstrated the efficacy of a temperature-sensitive hydrogel scaffold for delivering bone-marrow-derived MSCs into chronic diabetic wounds. This multifunctional hydrogel not only supports cell viability but also modulates the inflammatory milieu by attenuating pro-inflammatory macrophage phenotypes and enhancing MSC secretion of key trophic factors such as TGF-β1 and basic fibroblast growth factor. In vivo application in diabetic mouse models resulted in accelerated granulation tissue formation, neovascularisation, extracellular matrix deposition and re-epithelialisation, yielding markedly improved wound contraction and restored dermal architecture.

Mesenchymal Stem Cell Therapies in Wound Healing publication trend

The graph below shows the total number of articles in mesenchymal stem cell therapies in wound healing across all publications each year (not limited to Nature Index journals).

Technical terms

Mesenchymal Stem Cell: Adult progenitor cell capable of self-renewal and differentiation into multiple mesodermal lineages, used for regenerative therapies.

Paracrine signalling: Cell-to-cell communication through secretion of bioactive molecules that act on neighbouring cells.

Hydrogel scaffold: Water-rich polymer network engineered to support cell encapsulation and controlled delivery at injury sites.

Exosome: Nano-sized extracellular vesicle containing proteins, lipids and nucleic acids, mediating intercellular communication.

Angiogenesis: Formation of new blood vessels from pre-existing vasculature, essential for supplying nutrients to regenerating tissue.

Re-epithelialisation: Process by which keratinocytes migrate and proliferate to restore the epidermal barrier over a wound.

References

1. Rapid and Controllable Multilayer Cell Sheet Assembly via Biodegradable Nanochannel Membranes. Advanced Functional Materials (2024).
2. Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential. Stem Cells International (2018).
3. The Role of MSC in Wound Healing, Scarring and Regeneration. Cells (2021).
4. Mesenchymal stem cell-laden anti-inflammatory hydrogel enhances diabetic wound healing. Scientific Reports (2015).
5. Hypoxic Conditioned Medium from Human Amniotic Fluid-Derived Mesenchymal Stem Cells Accelerates Skin Wound Healing through TGF-β/SMAD2 and PI3K/Akt Pathways. International Journal of Molecular Sciences (2014).